Clinicial Trials Directory–
Show: » All Trials | Adult | Pediatric

Sally Arai's Trials

Drug Intervention Trials that are Recruiting

Study Title
Investigators
Disease Categories
Phase II Poor Risk Diffuse Large B-cell Lymphoma (DLBCL) of Total Lymphoid Irradiation (TLI) and Antithymocyte Globulin (ATG) Followed by Matched Allogeneic Hematopoietic Transplantation as Consolidation to Autologous Hematopoietic Cell Transplantation (AHCT)
Sandra Jeane Horning
Sally Arai
Karl G. Blume
Laura Johnston
Ginna Laport
Robert Lowsky
David Miklos
Robert S Negrin
Dr Andrew Quon
Judith Anne Shizuru
Wen-Kai Weng
Lymphoma, B-Cell
Imatinib Mesylate and Nilotinib After Donor Stem Cell Transplant in Treating Patients With Acute Lymphoblastic Leukemia or Chronic Myelogenous Leukemia
Laura Johnston
Sally Arai
Jonathan Benjamin
Ginna Laport
Robert Lowsky
David Miklos
Robert S Negrin
Judith Anne Shizuru
Wen-Kai Weng
Leukemia
Sirolimus as Treatment of Steroid-Refractory or Steroid-Dependent Chronic Graft-Versus-Host Disease
Rajni Agarwal-Hashmi
Laura J Johnston
Sally Arai
Karl G. Blume
Ginna Laport
Robert Lowsky
David Miklos
Robert S Negrin
Judith Anne Shizuru
Graft vs Host Disease
Gemcitabine and Hodgkin's Disease Chemotherapy Followed by Peripheral Blood Stem Cell Rescue for Hodgkin's Disease
Sandra Jeane Horning
Sally Arai
Karl G. Blume
Laura Johnston
Ginna Laport
Robert Lowsky
David Miklos
Robert S Negrin
Judith Anne Shizuru
Lymphoma
Lymphoma, Hodgkin Disease
Hodgkin Disease
Sirolimus/Tacrolimus Versus Tacrolimus/Methotrexate for Preventing Graft-Versus-Host Disease (GVHD)
Laura Johnston
Sally Arai
Ginna Laport
Robert Lowsky
David Miklos
Robert S Negrin
Judith Anne Shizuru
Kenneth Weinberg
Leukemia, Myelocytic, Acute
Myelodysplastic Syndromes
Cyclosporine Eye Drops in Preventing Graft-Versus-Host Disease of the Eye in Patients Who Have Undergone Donor Stem Cell Transplant for Hematologic Cancer or Bone Marrow Failure Disorder
Laura Johnston
Sally Arai
Ginna Laport
Robert Lowsky
David Miklos
Robert S Negrin
Judith Anne Shizuru
Christopher N Ta
Wen-Kai Weng
Myeloproliferative Disorders
Leukemia
Lymphoma
Graft vs Host Disease
Myelodysplastic Syndromes
Multiple Myeloma
Defibrotide for Hematopoietic SCT Patients With Severe Hepatic VOD: a Treatment IND Study
Sally Arai
Rajni Agarwal-Hashmi
Laura Johnston
Ginna Laport
Robert Lowsky
David Miklos
Robert S Negrin
Hepatic Veno-Occlusive Disease
Sirolimus & Mycophenolate Mofetil as GVHD prophylaxis in Myeloablative, Matched Related Donor HCT
Laura J Johnston
Rajni Agarwal-Hashmi
Sally Arai
Jonathan Benjamin
Ginna Laport
Robert Lowsky
David Miklos
Robert S Negrin
Judith Anne Shizuru
Wen-Kai Weng
Hematologic Diseases
A Phase II Trial of Rituximab and Corticosteroid Therapy for Newly Diagnosed Chronic Graft versus Host Disease
Karl G. Blume
Christopher C Dvorak
David Franklin Fiorentino
Laura Johnston
Ginna Laport
Philip Lavori
Robert Lowsky
Robert S Negrin
Judith Anne Shizuru
Youn H Kim
Sally Arai
David Miklos
Rajni Agarwal-Hashmi
Graft vs Host Disease

Other Trials that are Recruiting

Study Title
Investigators
Disease Categories
Ph II of Autologous Followed by Nonmyeloablative Allogeneic Transplantation Using TLI & ATG
Wen-Kai Weng
Sally Arai
Jonathan Benjamin
Laura Johnston
Ginna Laport
Robert Lowsky
David Miklos
Robert S Negrin
Judith Anne Shizuru
Transplantation, Homologous
Transplantation, Autologous
Multiple Myeloma
Phase II Poor Risk Diffuse Large B-cell Lymphoma (DLBCL) of Total Lymphoid Irradiation (TLI) and Antithymocyte Globulin (ATG) Followed by Matched Allogeneic Hematopoietic Transplantation as Consolidation to Autologous Hematopoietic Cell Transplantation (AHCT)
Sandra Jeane Horning
Sally Arai
Karl G. Blume
Laura Johnston
Ginna Laport
Robert Lowsky
David Miklos
Robert S Negrin
Dr Andrew Quon
Judith Anne Shizuru
Wen-Kai Weng
Lymphoma, B-Cell
Autologous Followed by Non-myeloablative Allogeneic Transplantation for Non-Hodgkin's Lymphoma
Sandra Jeane Horning
Laura Johnston
Ginna Laport
Robert Lowsky
David Miklos
Robert S Negrin
Judith Anne Shizuru
Wen-Kai Weng
Youn H Kim
Sally Arai
Karl G. Blume
Richard T. Hoppe
Lymphoma, Non-Hodgkin
Allogeneic HCT using Nonmyeloablative Host Conditioning with TLI & ATG vs SOC in AML
Robert Lowsky
Sally Arai
Jason Robert Gotlib
Laura Johnston
Ginna Laport
Bruno Carneiro de Medeiros
David Miklos
Robert S Negrin
Judith Anne Shizuru
Wen-Kai Weng
Leukemia, Myeloid
Ph II of Non-myeloablative Allgnc Trnsplnt Using TLI & ATG In Patients w/ Cutaneous T Cell Lymphoma
Wen-Kai Weng
Ranjana Hira Advani
Sally Arai
Jonathan Benjamin
Richard T. Hoppe
Laura A Johnson
Youn H Kim
Ginna Laport
Robert Lowsky
David Miklos
Robert S Negrin
Judith Anne Shizuru
Sezary Syndrome
Mycoses
Lymphoma, T-Cell, Cutaneous
NMDP Research Database for Allogeneic Unrelated Hematopoietic Stem Cell Transplantation
David Miklos
Michael D Amylon
Sally Arai
Karl G. Blume
Laura Johnston
Ginna Laport
Robert Lowsky
Robert S Negrin
Judith Anne Shizuru
Lymphoma, Non-Hodgkin
Leukemia, Lymphocytic
Multiple Myeloma
Chronic GVHD Cohort Protocol
Sally Arai
Laura Johnston
Ginna Laport
David Miklos
Robert S Negrin
Judith Anne Shizuru
Carcinomas (including Squamous Cell and Adenocarcinoma)
Research Sample Repository for Allogeneic Unrelated Hematopoietic Stem Cell Transplantation
Robert S Negrin
Rajni Agarwal-Hashmi
Sally Arai
Karl G. Blume
Laura Johnston
Ginna Laport
Robert Lowsky
David Miklos
Judith Anne Shizuru
Leukemia, Myeloid
Lymphoma, Non-Hodgkin
Multiple Myeloma
Gemcitabine and Hodgkin's Disease Chemotherapy Followed by Peripheral Blood Stem Cell Rescue for Hodgkin's Disease
Sandra Jeane Horning
Sally Arai
Karl G. Blume
Laura Johnston
Ginna Laport
Robert Lowsky
David Miklos
Robert S Negrin
Judith Anne Shizuru
Lymphoma
Lymphoma, Hodgkin Disease
Hodgkin Disease

Trials not Recruiting

Study Title
Investigators
Disease Categories
Mixed Chimera Allogeneic Transplantation From Matched Unrelated Donors For The Treatment Of Multiple Myeloma (Completed)
Sally Arai
Karl G. Blume
Laura Johnston
Ginna Laport
David Miklos
Robert S Negrin
Judith Anne Shizuru
Robert Lowsky
Multiple Myeloma
High Dose Chemotherapy and Allogeneic Hematopoietic Cell Transplant for Non-Hodgkin's Lymphoma (No longer recruiting)
Karl G. Blume
Sally Arai
Sandra Jeane Horning
Laura Johnston
Ginna Laport
Ronald Levy
Robert Lowsky
David Miklos
Judith Anne Shizuru
Wen-Kai Weng
Lymphoma, Non-Hodgkin
Defibrotide for the Treatment of Severe Hepatic Veno-Occlusive Disease in Hematopoetic Stem Cell Transplant Patients (No longer recruiting)
Sally Arai
Rajni Agarwal-Hashmi
Laura Johnston
Ginna Laport
Robert Lowsky
David Miklos
Robert S Negrin
Hepatic Veno-Occlusive Disease
Post-transplant Autologous Cytokine-induced Killer (CIK) Cells for Treatment of High Risk Hematologic Malignancies (No longer recruiting)
Sally Arai
Laura Johnston
Ginna Laport
Robert Lowsky
David Miklos
Robert S Negrin
Kevin Sheehan
Judith Anne Shizuru
Leukemia
Multiple Myeloma
Autologous Stem Cell Rescue for Primary Amyloidosis (No longer recruiting)
Karl G. Blume
Laura Johnston
Robert S Negrin
Sally Arai
Robert Lowsky
Amyloidosis
High -Dose Sequential Therapy and Single Autologous Transplantation for Multiple Myeloma (No longer recruiting)
Laura Johnston
Ginna Laport
Robert Lowsky
David Miklos
Robert S Negrin
Judith Anne Shizuru
Sally Arai
Multiple Myeloma
Vaccine Therapy for Multiple Myeloma Utilizing Idiotype-Pulsed Allogeneic Dendritic Cells (Completed)
Ronald Levy
Sally Arai
Dr. Ellie Guardino MD/PhD
Ginna Laport
Robert Lowsky
David Miklos
Ranjani Rajapaksa
Kevin Sheehan
Judith Anne Shizuru
Multiple Myeloma
Autologous Bone Marrow Transplantation in Acute Non-Lymphoblastic Leukemia During First or Subsequent Remission (No longer recruiting)
Laura Johnston
Sally Arai
Karl G. Blume
Robert S Negrin
Leukemia, Myelocytic, Acute
Prophylactic Use of Maribavir for the Prevention of Cytomegalovirus (CMV) Disease in Stem Cell Transplant Recipients (No longer recruiting)
Janice (Wes) Brown
Sally Arai
Dora Yuk-Wai Ho
Laura Johnston
Ginna Laport
Robert Lowsky
Robert S Negrin
Andrew Nevins MD
Judith Anne Shizuru
Cytomegalovirus Infections
A Randomized, Double-Blind, Placebo-Controlled Trial to Evaluate Palifermin (rHuKGF) in the Reduction of Acute Graft Versus Host Disease in Subjects With Hematologic Malignancies Undergoing Allogeneic Marrow/PBPC Transplantation (Completed)
Ginna Laport
Sally Arai
Laura Johnston
Robert Lowsky
David Miklos
Robert S Negrin
Judith Anne Shizuru
Graft vs Host Disease
Blood Cancer

Stanford Medicine Resources:

Footer Links: